IL18 and psoriasis: Another group of researchers from China showed that the combination of PlxnB2 and its soluble ligand, CD100, stimulates the production of IL-1β and IL-18 by keratinocytes and activates the NLRP3 inflammasome and the NF-kB pathway during the course of psoriasis [26].